Search results

The relationship between patents and the pharmaceutical industry is both complex and important. While many believe that patents are manipulated by the pharmaceutical industry for its own economic ends, a historical approach to the utilization of patents combined with an analysis of current patent issues places this relationship in its proper context. Though patents were created long before the pharmaceutical industry reached its current status as a major industry in the United States, a historical, analytic approach shows that the pharmaceutical industry has adjusted to constantly evolving legislation enacted to provide the most effective and efficient system by which to research, invent, regulate and patent new medicines.

Where is the Life we have lost in living?Where is the wisdom we have lost in knowledge?Where is the knowledge we have lost in information? Thomas Stearns Eliot.This book is a collection of multi-author contributed research devoted to exploring the synergy of new science-based health-risks approaches, innovative information technologies, and innovation in outcomes research. Time and again we find evidence that logistics of health care delivery calls for innovative approaches in every aspect of intervention, prevention, discovery, and insurance. Without transparency and real-time availability of adequate, multipurpose, reliable, health-risks and outcomes data, the needs of consumer safety, disease management, regulatory research, and targeted discovery will remain poorly equipped for either individual health system quality assurance or nation-wide decision-making. Each chapter in this collection strives to create knowledge by creating adequate data and advancing, at least, one step forward in the relevant field.